Glimfirst Mv2

GLIMFIRST MV2

• Name: GLIMFIRST MV2 (Tablet, ER, SR)

  • Manufacturer: SINSAN PHARMACEUTICALS PVT. LTD.

• Composition:

  • Glimepiride (2 mg)
  • Metformin (500 mg)
  • Voglibose (0.2 mg)

• Uses: GLIMFIRST MV2 is prescribed for the management of Type 2 Diabetes Mellitus in adults whose blood sugar levels are not adequately controlled by diet and exercise alone, or with single or two other anti-diabetic medications. This combination medicine helps lower both fasting and post-meal blood glucose levels. It works by stimulating the pancreas to produce more insulin, reducing glucose production by the liver, and slowing down carbohydrate absorption in the intestines. It also aims to improve insulin sensitivity and prevent serious complications of diabetes such as kidney damage, blindness, nerve problems, heart attack, and stroke.

• Dosage and Administration: GLIMFIRST MV2 should be taken orally as prescribed by a doctor, typically once daily with meals. It is important to swallow the tablet whole with a full glass of water, without chewing, crushing, or breaking it. Taking it at the same time each day is recommended to maintain consistent blood sugar control. Dosage adjustments should only be made by a healthcare professional based on individual blood sugar levels and response to treatment.

• Side Effects: Common side effects may include:

  • Hypoglycaemia (low blood sugar), characterized by symptoms such as sweating, shakiness, hunger, confusion, dizziness, and weakness.
  • Nausea, vomiting, diarrhoea, abdominal pain, flatulence, stomach discomfort.
  • Headache, dizziness.
  • Skin rash, taste change, metallic taste.
  • Upper respiratory tract infection, loss of appetite. Serious but rare side effects include lactic acidosis, which can manifest as extreme fatigue, body weakness, and diarrhoea.

• Precautions: GLIMFIRST MV2 is contraindicated during pregnancy and breastfeeding. It should not be used in patients with severe kidney or liver dysfunction, Type 1 diabetes mellitus, diabetic ketoacidosis, severe ketosis, severe trauma, lung problems, or heart problems. Alcohol consumption should be avoided as it can increase the risk of hypoglycaemia and lactic acidosis. Caution is advised for patients with mild to moderate liver impairment or those aged 75 years or older. Patients should inform their doctor about any allergies to the medicine's components, pre-existing conditions, or other medications they are taking. Regular blood sugar monitoring is essential.

• Storage: Store GLIMFIRST MV2 in a cool and dry place, away from direct sunlight. It should be kept out of sight and reach of children. Storage temperatures typically range from 10ºC to 25ºC or below 30ºC.

GLIMFIRST MV2 is a combination medication used to manage Type 2 Diabetes Mellitus. It contains three active ingredients: Glimepiride, Metformin, and Voglibose, which work together to help control blood sugar levels.

Here are some frequently asked questions about GLIMFIRST MV2:

What is GLIMFIRST MV2 used for?

GLIMFIRST MV2 is primarily used to treat Type 2 Diabetes Mellitus in adults. It is prescribed when diet and exercise alone, or treatment with a single or two anti-diabetic medications, are not sufficient to adequately control blood sugar levels. It helps manage high blood sugar, regulate post-meal glucose spikes, improve insulin sensitivity, and enhance pancreatic insulin production.

How does GLIMFIRST MV2 work?

GLIMFIRST MV2 is a combination of three anti-diabetic drugs, each with a distinct mechanism of action:

• Glimepiride: This sulfonylurea stimulates the pancreas to release more insulin, which helps lower blood sugar by allowing cells to take in glucose.
• Metformin: This biguanide reduces glucose production in the liver, delays the absorption of glucose from the intestines, and improves the body's response to insulin, leading to better glucose uptake and utilization by body tissues.
• Voglibose: This alpha-glucosidase inhibitor works in the intestines by preventing the breakdown of complex sugars into simpler ones, thereby slowing down glucose absorption into the bloodstream and preventing sharp rises in blood sugar after meals.

What is the usual dosage of GLIMFIRST MV2?

The dosage of GLIMFIRST MV2 is determined by your doctor and can vary based on your blood sugar levels and how you respond to treatment. It should be taken as prescribed by your doctor, usually once or twice daily with meals. It is crucial not to adjust the dose without consulting your doctor.

What are the possible side effects of GLIMFIRST MV2?

Common side effects of GLIMFIRST MV2 can include hypoglycemia (low blood sugar levels), nausea, diarrhea, abdominal pain, taste changes, headache, and upper respiratory symptoms. Less common but serious side effects can include lactic acidosis, especially in patients with kidney problems. If you experience severe side effects or any worsening symptoms, contact your doctor immediately.

Is GLIMFIRST MV2 safe during pregnancy or breastfeeding?

GLIMFIRST MV2 is generally not recommended during pregnancy, especially in the second and third trimesters, as it may cause harm to the developing fetus. Similarly, it is not recommended during breastfeeding because its components can pass into breast milk and may harm the nursing child. Always consult your doctor if you are pregnant, planning to conceive, or breastfeeding.

Can GLIMFIRST MV2 be taken with other medications?

GLIMFIRST MV2 can interact with various medications. For example, taking it with insulin or other anti-diabetic medicines may increase the risk of hypoglycemia. Certain medications like corticosteroids, thiazide diuretics, antibacterials (e.g., rifampicin, ciprofloxacin), antifungals (e.g., fluconazole), and some anticancer drugs can affect its effectiveness or interact with it. Inform your doctor about all medications, including over-the-counter drugs and herbal supplements, you are currently taking to avoid undesirable effects.

What precautions should be taken with GLIMFIRST MV2?

Several precautions should be observed:

• Allergies: Do not take GLIMFIRST MV2 if you are allergic to any of its components or other sulfonylureas or sulphonamides.
• Kidney and Liver Conditions: This medicine is contraindicated in severe kidney or liver disease. Caution is advised with mild to moderate liver impairment.
• Alcohol: Avoid alcohol consumption while taking GLIMFIRST MV2 as it can increase the risk of low blood sugar (hypoglycemia) and a rare but serious condition called lactic acidosis.
• Diet and Exercise: Continue to follow a recommended diet and exercise plan while on this medication.
• Hypoglycemia: Be aware of the symptoms of low blood sugar and carry a quick source of sugar (like glucose tablets, honey, or fruit juice). Do not skip meals.
• Other Conditions: Inform your doctor if you have heart disease, pancreatitis, a low vitamin B12 level, type 1 diabetes, or diabetic ketoacidosis, as the medication might not be suitable.
• Sudden Stoppage: Do not stop taking the medicine abruptly without consulting your doctor, as this can lead to increased sugar levels and potential complications.

What happens if a dose is missed?

If you miss a dose of GLIMFIRST MV2, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular schedule. Do not take a double dose to make up for a missed one.

How should GLIMFIRST MV2 be stored?

GLIMFIRST MV2 should be stored in a cool, dry place, away from direct sunlight, heat, and moisture. Keep the medicine in its original container, tightly closed, and out of sight and reach of children and pets. The storage temperature should generally be below 30°C.